Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
How Patients With Multiple Sclerosis Perceive Cognitive Slowing.
Significant increase in the prevalence of multiple sclerosis in iran in 2011.
Metric Optimization for Surface Analysis in the Laplace-Beltrami Embedding Space.
Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients.
Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue.
4-Аminopyridine sequesters intracellular Ca(2+) which triggers exocytosis in excitable and non-excitable cells.
Multidisciplinary management of multiple sclerosis symptoms.
NAD(+) protects against EAE by regulating CD4(+) T-cell differentiation.
Hughes syndrome and Multiple sclerosis.
cFLIP is critical for oligodendrocyte protection from inflammation.
Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
Mast cells on the mind: new insights and opportunities.
The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Heligmosmoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Quantitative Susceptibility Mapping in Multiple Sclerosis.
[Current state of research on multiple sclerosis].
Diffusion restriction of the optic nerve in patients with acute visual deficit.
Training of Respiratory Muscles in Patients With Multiple Sclerosis: A Systematic Review.
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »